CME.NASDAQCme Group INC

Form 4: CME Group Director Receives Stock Grant

Sentiment:

Statement of Changes in Beneficial Ownership


CME Group Director Daniel G. Kaye was granted fully vested Class A Common Stock as part of the company's annual equity compensation program.

Summary

  • Daniel G. Kaye, a Director at CME Group Inc., received a grant of 645 shares of Class A Common Stock on June 25, 2026.
  • These shares were issued as part of the company's annual equity compensation program for non-employee directors under the CME Group Director Stock Plan.
  • The shares are fully vested and not subject to any vesting conditions.
  • Following this transaction, Mr. Kaye beneficially owns 4,845 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine equity grant to a director as part of a standard compensation program and does not indicate significant new financial performance or strategic shifts.

Positives

  • Director compensation through equity awards aligns with shareholder interests.
  • The grant of fully vested shares indicates immediate recognition of the director's contribution.
  • The transaction is part of a standard annual compensation program, suggesting consistent governance practices.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it pertains to a director's stock grant.

Industry Context

StockSavvy.ai notes that the issuance of equity compensation to directors is a common practice in the financial services and exchange industry, aimed at attracting and retaining experienced leadership and aligning their interests with those of shareholders. CME Group's use of a Director Stock Plan is consistent with industry norms.

Stakeholder Impact

  • Shareholders: The grant is part of a compensation plan, which is a standard operating expense. The alignment of director compensation with stock ownership can be seen as positive for long-term shareholder value.
  • Employees: This filing does not directly impact employees, but it is part of the overall compensation structure for the company's leadership.
  • Management: The filing confirms the ongoing compensation practices for non-employee directors.

Key Dates

DateDescription
05/06/2026Date of Power of Attorney for EDGAR Administration
06/25/2026Transaction Date: Grant of Class A Common Stock
06/29/2026Date of Signature on Form 4

Keywords

CME Group, Form 4, Director Stock Plan, Equity Compensation, Class A Common Stock, Beneficial Ownership, SEC Filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.